Indegene Receives Frost & Sullivan's 2026 Global Enabling Technology Leadership Recognition for AI-Powered Pharma Commercialization

What happened: Frost & Sullivan gave Indegene its 2026 Global Enabling Technology Leadership Recognition in pharma AI-powered commercialization services, citing domain-led AI, knowledge orchestration, and integrated execution. Key numbers: Recognition dated Oct. 22, 2026. Why it matters: Frost & Sullivan said Indegene's approach moves beyond isolated automation to governed, connected workflows. Indegene said the recognition reinforces its view that value comes from connecting intelligence, decisions, and execution.

Frost & Sullivan gave Indegene its 2026 Global Enabling Technology Leadership Recognition in pharma AI-powered commercialization services, citing domain-led AI, knowledge orchestration, and integrated execution.

Frost & Sullivan said Indegene's approach moves beyond isolated automation to governed, connected workflows. Indegene said the recognition reinforces its view that value comes from connecting intelligence, decisions, and execution.